Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Oxyargin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxyargin 40mg/20mg modified-release tablets
0407020AFBDADAD
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Oxyargin 5mg/2.5mg modified-release tablets
0407020AFBDAAAC
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Oxyargin 10mg/5mg modified-release tablets
0407020AFBDABAA
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Oxyargin 20mg/10mg modified-release tablets
0407020AFBDACAB
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.